The Oncology InstituteTOIIW -45.27%56 Days Inventory is 15.13 as of Mar. 2026, which is 25% above its 10-year median of 12.15. GuruFocus rates TOIIW with a GF Score™ of 56/100. The stock has 6 warning signs investors should review. Among 497 Healthcare Providers & Services companies, The Oncology Institute ranks better than 73.04% on this metric.
The historical rank and industry rank for The Oncology Institute's Days Inventory or its related term are showing as below:
TOIIW'
s Days Inventory Range Over the Past 10 Years
Min: 9.99 Med: 12.15 Max: 15.82
Current: 13.89
During the past 8 years, The Oncology Institute's highest Days Inventory was 15.82. The lowest was 9.99. And the median was 12.15.
TOIIW's Days Inventory is ranked better than 73.04% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 30.42
vs TOIIW: 13.89
Inventory Turnover measures how fast the company turns over its inventory within a year.
The Oncology Institute's Inventory Turnover for the
three
months ended in Mar. 2026 was 6.03.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
The Oncology Institute's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.14.
The Oncology Institute (NAS:TOIIW) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
The Oncology Institute's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
The Oncology Institute's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
The Oncology Institute Days Inventory Related Terms
The Oncology Institute Days Inventory Historical Data
* Premium members only.
The historical data trend for The Oncology Institute's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOIIW vs CCRN, SRTA, CYH: Days Inventory Comparison
For the Medical Care Facilities subindustry, The Oncology Institute's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Oncology Institute Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Oncology Institute's Days Inventory distribution charts can be found below:
* The bar in red indicates where The Oncology Institute's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Oncology Institute (TOIIW) has a Days Inventory of 15.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on The Oncology Institute and its competitors. This is 25% above median its historical median of 12.15. Over the past decade, The Oncology Institute's Days Inventory has ranged from 9.99 to 15.82. According to the industry distribution chart, The Oncology Institute ranks #134 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 27%.
Is The Oncology Institute's Days Inventory too high?
The Oncology Institute's current Days Inventory of 15.13 is 25% above median its 10-year median of 12.15. Over the past 10 years, this metric has ranged from a low of 9.99 to a high of 15.82. The Healthcare Providers & Services industry median Days Inventory is 30.42. The Oncology Institute's value of 15.13 is 50.3% below this industry median. Based on the distribution chart, The Oncology Institute ranks #134 out of 497 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Oncology Institute has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's Days Inventory compare to CCRN and SRTA?
According to the Healthcare Providers & Services industry distribution chart, The Oncology Institute ranks #134 out of 497 companies for Days Inventory. This puts The Oncology Institute in the upper half of its industry. The industry median Days Inventory is 30.42. The Oncology Institute's value of 15.13 is 50.3% below this benchmark. Historically, The Oncology Institute's own Days Inventory has ranged from 9.99 to 15.82 over the past decade. While the company's 10-year median is 12.15 vs. the industry median of 30.42, The Oncology Institute has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.42, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Oncology Institute's current Days Inventory of 15.13 is 50.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on The Oncology Institute and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Oncology Institute's current Days Inventory is 15.13, which is 25% above median its own 10-year median of 12.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current Days Inventory of 15.13. The current Days Inventory is 15.13, which is 25% above median its 10-year median of 12.15 and 50.3% below the Healthcare Providers & Services industry median of 30.42. The Oncology Institute's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current Days Inventory is 15.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
56GF Score
Get the complete analysis for TOIIW
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TOIIW has been successfully added to your 
